Bi-weekly snapshot of market access and HEOR project work at MTRC – 15 June 2026 edition

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.

From the week of June 15th, we are planning to work on 18 projects, including:

Reimbursement

1. Delivering market access strategy for minimally invasive technology in vascular surgery in Denmark, England, France, Germany, Italy, Sweden, and Switzerland
2. Working on market access strategy for minimally invasive technologies in oncology and vascular surgery in England, Germany, and the Netherlands
3. Working on reimbursement analysis and market access strategy for minimally invasive surgical technology in pulmonary, urology, gynecology, and general surgery areas in Belgium, England, France, Germany, Italy, and the Netherlands
4. Working on reimbursement analysis for implanted medical devices in the surgical area in Belgium, Germany, and Switzerland
5. Working on reimbursement analysis for minimally invasive vascular interventions in England, Germany, and the Netherlands
6. Working on reimbursement analysis for surgical treatment in the ophthalmology area in England, France, Italy, the Netherlands, Spain, Sweden, and Switzerland
7. Initiating work on reimbursement analysis for an in-vitro diagnostic test in infectious disease areas in England, France, Germany, and Spain
8. Initiating work on analysis or coverage and reimbursement framework for point-of-care tests in England, Germany, Italy, the Netherlands, and Spain
9. Initiating work on market size analysis for diagnostic technology in the neurology area in Germany
10. Initiating work on reimbursement and HTA analysis for minimally invasive surgery in the cardiovascular area in Germany and Spain

HEOR

1. Delivering an adaptation of a health economic model for an imaging diagnostic system in different European and Middle Eastern countries
2. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
3. Delivering validation of a health economic model in the cardiology area
4. Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
5. Working on the development of a health economic model for technology in the cardiovascular area in England
6. Working on evidence gap analysis for minimally invasive technology in vascular surgery 
7. Working on the development of a value dossier for a neuromodulation therapy in the neurology area
8. Working on the development of a value dossier for a personalized blood test in the oncology area

Let us know if you need any market access or HEOR support for your medical technology in Europe